Supplemental material, Supplemental table2 for Work and Female Breast Cancer: The State of the Evidence, 2002–2017 by Connie L. Engel, M. Sharima Rasanayagam, Janet M. Gray and Jeanne Rizzo in NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy</p
Supplemental material, Supplemental Material1 for Breast cancer subtype and screening sensitivity in...
Supplemental material, Table_S1 for Prognostic nomogram for patients with non-metastatic HER2 positi...
Supplementary Table 2 shows crude and adjusted rate ratios for all applicable outcomes stratified by...
Supplemental material, Supplemental table1 for Work and Female Breast Cancer: The State of the Evide...
Supplemental material, Supplemental table3 for Work and Female Breast Cancer: The State of the Evide...
<p>Supplemental material, Supplemental Material1 for Work and Female Breast Cancer: The State of the...
<p>Supplemental material, Supplemental Material3 for Work and Female Breast Cancer: The State of the...
Supplemental material, Supplemental Material2 for Work and Breast Cancer: Recommendations to Address...
Supplemental material, Supplemental Material1 for Work and Breast Cancer: Recommendations to Address...
Supplemental material, Supplemental Material3 for Work and Breast Cancer: Recommendations to Address...
Supplemental material, Supplemental Material2 for Breast cancer subtype and screening sensitivity in...
Supplemental material, Supplemental material2 for Clinical oncology pharmacist: Effective contributi...
<p>Supplemental material, DS_10.1177_0272989X17717981 for Contribution of Breast Cancer to Overall M...
Supplemental material, Rosell-supplementary_table_1-190204 for Function, information, and contributi...
Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a low risk according to...
Supplemental material, Supplemental Material1 for Breast cancer subtype and screening sensitivity in...
Supplemental material, Table_S1 for Prognostic nomogram for patients with non-metastatic HER2 positi...
Supplementary Table 2 shows crude and adjusted rate ratios for all applicable outcomes stratified by...
Supplemental material, Supplemental table1 for Work and Female Breast Cancer: The State of the Evide...
Supplemental material, Supplemental table3 for Work and Female Breast Cancer: The State of the Evide...
<p>Supplemental material, Supplemental Material1 for Work and Female Breast Cancer: The State of the...
<p>Supplemental material, Supplemental Material3 for Work and Female Breast Cancer: The State of the...
Supplemental material, Supplemental Material2 for Work and Breast Cancer: Recommendations to Address...
Supplemental material, Supplemental Material1 for Work and Breast Cancer: Recommendations to Address...
Supplemental material, Supplemental Material3 for Work and Breast Cancer: Recommendations to Address...
Supplemental material, Supplemental Material2 for Breast cancer subtype and screening sensitivity in...
Supplemental material, Supplemental material2 for Clinical oncology pharmacist: Effective contributi...
<p>Supplemental material, DS_10.1177_0272989X17717981 for Contribution of Breast Cancer to Overall M...
Supplemental material, Rosell-supplementary_table_1-190204 for Function, information, and contributi...
Sensitivity Analysis of cost effectiveness of chemotherapy in subgroups with a low risk according to...
Supplemental material, Supplemental Material1 for Breast cancer subtype and screening sensitivity in...
Supplemental material, Table_S1 for Prognostic nomogram for patients with non-metastatic HER2 positi...
Supplementary Table 2 shows crude and adjusted rate ratios for all applicable outcomes stratified by...